SMTL ID : 4drh.2 (1 other biounit)

Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low pH

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x RAP: RAPAMYCIN IMMUNOSUPPRESSANT DRUG(Non-covalent)

RAP.1: 24 residues within 4Å: Chain A: Y.61, F.71, D.72, H.75, F.81, G.88, Q.89, V.90, I.91, W.94, Y.117, L.123, P.124, I.126, F.134 Chain B: L.15, S.19, R.20, F.23, T.82, W.85, D.86, Y.89, F.92 29 PLIP interactions: 15 interactions with chain A, 14 interactions with chain B Hydrophobic interactions: A:Y.61, A:F.81, A:F.81, A:V.90, A:I.91, A:W.94, A:W.94, A:Y.117, A:I.126, B:L.15, B:F.23, B:F.23, B:F.23, B:F.23, B:F.23, B:F.23, B:W.85, B:W.85, B:Y.89, B:Y.89, B:Y.89, B:F.92, B:F.92 Hydrogen bonds: A:D.72, A:D.72, A:I.91, A:Y.117 Water bridges: A:G.88, A:G.88

10 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: S.17, P.18, T.19, K.64 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:T.19, A:T.19, A:T.19 Salt bridges: A:K.64 SO4.3: 5 residues within 4Å: Chain A: E.16, P.18, K.42, H.108, E.135 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.16 Salt bridges: A:K.42, A:H.108 SO4.4: 6 residues within 4Å: Chain A: F.71, D.72, S.73, S.74, H.75 Chain B: T.82 5 PLIP interactions: 1 interactions with chain B, 4 interactions with chain A Water bridges: B:T.82, A:D.72 Hydrogen bonds: A:S.73, A:S.74, A:S.74 SO4.5: 3 residues within 4Å: Chain A: K.62, K.64, K.70 3 PLIP interactions: 3 interactions with chain A Salt bridges: A:K.62, A:K.64, A:K.70 SO4.6: 4 residues within 4Å: Chain A: V.82 Chain B: Y.89, H.90, R.93 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:Y.89 Salt bridges: B:H.90, B:R.93 Water bridges: A:V.82 SO4.7: 2 residues within 4Å: Chain B: R.70 Ligands: SO4.10 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:R.70 SO4.8: 3 residues within 4Å: Chain A: K.56, Y.58 Chain B: R.93 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Y.58 Salt bridges: A:K.56, B:R.93 SO4.9: 3 residues within 4Å: Chain B: H.12, E.13, E.16 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:H.12 SO4.10: 6 residues within 4Å: Chain B: F.32, E.36, Q.66, C.69, R.70 Ligands: SO4.7 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:E.36 SO4.11: 2 residues within 4Å: Chain B: D.61, H.90 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:D.61 Salt bridges: B:H.90, B:R.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Marz, A.M. et al., Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin. Mol.Cell.Biol. (2013)

Release Date

2013-02-06

Peptides

Peptidyl-prolyl cis-trans isomerase FKBP5: A
Serine/threonine-protein kinase mTOR: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

Peptidyl-prolyl cis-trans isomerase FKBP5

Serine/threonine-protein kinase mTOR

Related Entries With Identical Sequence